Literature DB >> 7783764

Amyotrophic lateral sclerosis is a multifactorial disease.

A Eisen1.   

Abstract

Amyotrophic lateral sclerosis (ALS) is probably biphasic. An initial trigger(s) is followed by a terminal cascade coinciding with the onset of neurological deficits. The terminal cascade involves interactive multifactorial pathogenic mechanisms. Aging must play a crucial role leading to multiple defective or degraded gene products accumulating with progressing years. This in turn leads to failure of receptor integrity and resulting excitotoxicity, free radical accumulation, failure of neurotrophism, and possibly immunological disturbances. These events are predated by months or years by a trigger which is also likely to be multifactorial and cumulative. Evidence suggests that environmental factors may be important triggers. Failure of specific glutamate transporters and calcium binding proteins may account for selective vulnerability of the corticomotoneuronal system. It is postulated that in ALS the primary target cell is the corticomotoneuron or the local circuit interneurons which modulate its activity. Glia cells may play an important role in the demise of the corticomotoneuronal cell. The disordered corticomotoneuron induces excessive excitatory transmitter (glutamate?) release at the corticomotoneuronal-spinal-motoneuronal synapse resulting in the subsequent demise of this neuron.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7783764     DOI: 10.1002/mus.880180711

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  16 in total

Review 1.  Treatment of amyotrophic lateral sclerosis.

Authors:  A Eisen; M Weber
Journal:  Drugs Aging       Date:  1999-03       Impact factor: 3.923

2.  Evaluation of antioxidants, protein, and lipid oxidation products in blood from sporadic amyotrophic lateral sclerosis patients.

Authors:  P I Oteiza; O D Uchitel; F Carrasquedo; A L Dubrovski; J C Roma; C G Fraga
Journal:  Neurochem Res       Date:  1997-04       Impact factor: 3.996

3.  Endogenous female reproductive hormones and the risk of amyotrophic lateral sclerosis.

Authors:  Sonja de Jong; Mark Huisman; Nadia Sutedja; Anneke van der Kooi; Marianne de Visser; Jurgen Schelhaas; Yvonne van der Schouw; Jan Veldink; Leonard van den Berg
Journal:  J Neurol       Date:  2012-09-13       Impact factor: 4.849

4.  Transgenic mice for interleukin 3 develop motor neuron degeneration associated with autoimmune reaction against spinal cord motor neurons.

Authors:  C Chavany; C Vicario-Abejón; G Miller; M Jendoubi
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-15       Impact factor: 11.205

5.  Kinesin mutations cause motor neuron disease phenotypes by disrupting fast axonal transport in Drosophila.

Authors:  D D Hurd; W M Saxton
Journal:  Genetics       Date:  1996-11       Impact factor: 4.562

6.  Prevalence of amyotrophic lateral sclerosis in the United States using established and novel methodologies, 2017.

Authors:  Paul Mehta; Jaime Raymond; Reshma Punjani; Moon Han; Theodore Larson; Wendy Kaye; Lorene M Nelson; Barbara Topol; Oleg Muravov; Corina Genson; D Kevin Horton
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2022-04-15       Impact factor: 3.528

7.  Oxidative stress and superoxide dismutase in development, aging and gene regulation.

Authors:  R G Allen
Journal:  Age (Omaha)       Date:  1998-04

8.  Feasibility of creating a National ALS Registry using administrative data in the United States.

Authors:  Wendy E Kaye; Marchelle Sanchez; Jennifer Wu
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2014-03-06       Impact factor: 4.092

9.  Talampanel reduces the level of motoneuronal calcium in transgenic mutant SOD1 mice only if applied presymptomatically.

Authors:  Melinda Paizs; Massimo Tortarolo; Caterina Bendotti; József I Engelhardt; László Siklós
Journal:  Amyotroph Lateral Scler       Date:  2011-05-30

10.  Mapping amyotrophic lateral sclerosis lake risk factors across northern New England.

Authors:  Nathan Torbick; Sarah Hession; Elijah Stommel; Tracie Caller
Journal:  Int J Health Geogr       Date:  2014-01-02       Impact factor: 3.918

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.